Meet the Lochmüller Lab Clinical Team

Neuromuscular Clinic for adult patients at The Ottawa Hospital (TOH) Civic Campus

As part of the team led by Dr. Jodi Warman Chardon, Hanns sees neuromuscular patients in clinic at the Ottawa Neuromuscular Centre, located at the Civic Campus of The Ottawa Hospital.  This newly opened state-of-the-art centre is a leading clinical research centre established to improve diagnosis and care for adults with neuromuscular diseases (NMD) and participating in clinical trials for several novel therapies.

Brenda Barasa is the Clinical Assistant at TOH and is responsible for coordinating Dr. Lochmüller’s neuromuscular clinic.

Neuromuscular Clinic for paediatric patients at CHEO

As part of the team led by Dr. Anna McCormick, Hanns sees neuromuscular patients in multidisciplinary clinic at CHEO.  The clinic provides diagnosis and care for children with NMDs and is also an active clinical trial site, participating in the development and clinical testing of cutting-edge therapies for these rare disorders.

 

Meet the Lochmüller Lab Clinical Research Team

As a part of the Lochmüller Lab, the clinical research team consists of four members who help run and support the lab’s clinical work, which includes both adult and pediatric trials, as well as patient registries, and natural history studies.

You can find a list of trials that the clinical research team is currently involved with here, as well as learn about the different types of clinical research on the Clinical research page of the Lochmüller Lab site.

 

Brenda Barasa | Clinical Assistant, OHRI

Brenda is responsible for coordinating Dr. Lochmüller’s neuromuscular clinic at The Ottawa Hospital and occasionally at CHEO. Brenda holds a BSc in Biochemistry with years of clinical experience working in the hospital and community-based health centres.

 

Emilie Hill-Smith | Research Coordinator, CHEO RI

Emilie coordinates various neuromuscular disease trials for Dr. Lochmüller. Emilie holds a master’s degree in Anthropology and a BA in Child Studies. Her research has focused on pediatric palliative care more specifically; her master’s research investigated the lives of siblings of children accessing palliative care at Roger Neilson House. Before joining Dr. Lochmüller’s team, Emilie worked as a Grants Coordinator at the CHEO RI running the internal grants program as well as assisting with external grant submissions.

 

Laura Thompson | Neurology Research Coordinator, CHEO RI

In September 2020 Laura joined the CHEO RI as a research coordinator in Neurology. She currently coordinates various neuromuscular disease trials with Dr. Hugh McMillan and Dr. Hanns Lochmuller. Laura holds a master’s degree in Health Psychology from Carleton University.  Over the last 6 years she worked with the Bruyère Research Institute specializing in cognitive aging research. Her research work focused primarily on Neuropsychological assessments and clinical drug trials for those with dementia.

 

Matthew MacDonald | Research Coordinator, CHEO RI

Matthew joined the team in June 2021 as a Research Coordinator, working on several neuromuscular disease clinical trials for Dr. Lochmüller. Before joining the lab, Matthew coordinated several high-volume gastrointestinal cancer therapeutics trials at The Ottawa Hospital Cancer Centre. Prior to this, he was part of the Epic health information system implementation (Project Fusion) for The Ottawa Hospital and Atlas Alliance hospitals, focusing on launching the Epic research module for Coordinators and Clinicians at the Ottawa Hospital Research Institute.

meetClinicalTeam

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...